LONDON (Reuters) - GlaxoSmithKline (GSKL) and Google parent Alphabet's (GOOGLO) life sciences unit are creating a new company focussed on fighting diseases by targeting electrical signals in the body  jump-starting a novel field of medicine called bioelectronics